Skip to content
StockMarketAgent
Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

STO/PROGEN stock hub

STO/PROGEN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

STO/PROGENis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
43.8M
Nasdaq Stockholm
Market data

Price

Recent price action with selectable time range.

STO/PROGENSTO/PROGEN
Loading chart…
In the news

Latest news · STO/PROGEN

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-148.3
P25 n/aP50 n/aP75 n/a
ROIC-81
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All STO/PROGEN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
165
Groups with data
11
Currency
SEK
Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Sweden
Country code
SE
Employees
6
Employees Change
0%
Employees Change Percent
0
Enterprise value
SEK 34.7M
Exchange
Nasdaq Stockholm
Financial currency
SEK
First seen
2026-05-10
Industry
Diagnostics & Research
Isin
SE0014684569
Last refreshed
2026-05-10
Market cap
SEK 43.8M
Price
SEK 0.74
Price currency
SEK
Rev Per Employee
99,000x
Sector
Healthcare
Sic
2835
Symbol
sto/PROGEN
Website
https://www.prostatypegenomics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-101.6%
EV Earnings
-0.78x
EV/FCF
-1.44x
EV/Sales
58.47x
FCF yield
-54.93%
P/B ratio
1.65x
P/S ratio
73.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

11
MetricValue
Gross Profit
SEK -20.2M
Net Income
SEK -44.5M
Net Income Growth Years
0%
Pretax Margin
-7,492.09%
Profit Per Employee
SEK -7.4M
ROA
-52.43
Roa5y
-49.27
ROCE
-146.8
ROE
-148.3
Roe5y
-119
ROIC
-81.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

10
MetricValue
Cagr1y
-55.04%
Cagr3y
-87.93%
Cagr5y
-82.64%
EPS Growth Quarters
5
EPS Growth Years
1
Revenue Growth
-69.03x
Revenue Growth Q
-25.96x
Revenue Growth Years
1x
Revenue Growth3 Y
-47.55x
Revenue Growth5 Y
-16.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Asset Turnover
SEK 0.01
Assets
SEK 50.9M
Cash
SEK 9.1M
Current Assets
SEK 10.6M
Current Liabilities
SEK 24.3M
Equity
SEK 26.5M
Interest Coverage
-24.11
Liabilities
SEK 24.3M
Long Term Assets
SEK 40.2M
Long Term Liabilities
SEK 0
Net Cash
SEK 9.1M
Net Cash By Market Cap
SEK 20.7
Net Cash Growth
-3.05%
Net Debt Equity
SEK -0.34
Tangible Book Value
SEK -12.8M
Tangible Book Value Per Share
SEK -0.22
WACC
12.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.44
Inventory Turnover
240.4
Net Working Capital
SEK -22.8M
Quick ratio
0.43
Working Capital
SEK -13.7M
Working Capital Turnover
SEK -0.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-2,294.79%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-55.02%
200-day SMA
0.83
3Y total return
-99.82%
50-day SMA
0.89
50-day SMA vs 200-day SMA
50over200
5Y total return
-99.98%
All Time High
18,400
All Time High Change
-100%
All Time High Date
2021-01-08
All Time Low
0.28
All Time Low Change
164.29%
All Time Low Date
2026-01-02
ATR
0.1
Beta
1.52
Beta1y
-0.93
Beta2y
-1.8
Ch YTD
146.7
High
0.76
High52
3.56
High52 Date
2025-06-02
High52ch
-79.21%
Low
0.61
Low52
0.28
Low52 Date
2026-01-02
Low52ch
164.29%
Ma50ch
-16.58%
Price vs 200-day SMA
-10.68%
RSI
42.67
RSI Monthly
36.51
RSI Weekly
41.4
Sharpe ratio
0.29x
Sortino ratio
0.53
Total Return
-2,294.79%
Tr YTD
146.7
Tr1m
-16.85%
Tr1w
-3.39%
Tr3m
-48.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
SEK -38.9M
Operating margin
-6,555.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
56,048,191%
Net Borrowing
5,233,000
Shares Insiders
4.7%
Shares Out
59,189,321
Shares Qo Q
201.07%
Shares Yo Y
2,294.79%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

48
MetricValue
Adjusted FCF
SEK -24.1M
Average Volume
86,258.65x
Bv Per Share
0.45
CAPEX
SEK -258,000
Ch1m
-16.85
Ch1w
-3.39
Ch1y
-55.02
Ch3m
-48.25
Ch3y
-99.82
Ch5y
-99.99
Ch6m
30.74
Change
5.71%
Change From Open
5.71
Close
0.7
Days Gap
0
Depreciation Amortization
2,187,000
Dollar Volume
45,043.8
Earnings Date
2026-05-13
EBIT
SEK -38.9M
EBITDA
SEK -36.8M
EPS
SEK -1.32
F Score
1
FCF
SEK -24.1M
FCF EV Yield
-69.27x
FCF Per Share
SEK -0.41
Financing CF
36,831,000
Fiscal Year End
December
Founded
2,007
Investing CF
-13,359,000
Is Primary Listing
1
Last Earnings Date
2026-02-12
Last Report Date
2025-12-31
Last Split Date
2024-10-31
Last Split Type
Reverse
Ma150
0.86
Ma150ch
-13.75%
Ma20
0.78
Ma20ch
-5.38%
Net CF
-352,000
Next Earnings Date
2026-05-13
Open
0.7
Position In Range
86.67
Ppne
452,000
Price Date
2026-05-08
Relative Volume
0.69x
Revenue
594,000x
Tr6m
30.74%
Volume
60,870
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does STO/PROGEN pay a dividend?

Capital-return profile for this ticker.

Performance

STO/PROGEN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-55.0%
S&P 500 1Y: n/a
3Y total return
-99.8%
S&P 500 3Y: n/a
5Y total return
-100.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns STO/PROGEN?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+4.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+2294.8%
Negative means the company is buying back shares.
Technical

STO/PROGEN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
42.7
Neutral momentum band
Price vs 200-day MA
-10.7%
50/200-day relationship not available
Beta (5Y)
1.52
More volatile than the market
Sharpe ratio
0.29
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About STO/PROGEN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/PROGEN stock rating?

sto/PROGEN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/PROGEN analysis?

The full report lives at /stocks/sto/PROGEN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/PROGEN?

The latest report frames sto/PROGEN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/PROGEN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.